For more information, contact:
Cindy Lorentzen, Marketing Specialist
414-287-9622
clorentzen@gklaw.com
FOR IMMEDIATE RELEASE
Madison, Wisconsin (June 24, 2005). The law firm of Godfrey & Kahn, S.C. has announced the addition of Colin L. Fairman to the Intellectual Practice Group in its Madison office, LaFollette Godfrey & Kahn. He offers a unique business perspective based on his more than 15 years of scientific experience.
Fairman’s practice focuses on identification, acquisition, enforcement, prosecution and licensing of intellectual property, with a particular emphasis in biotechnology and nanotechnology. His work includes client counseling and patent prosecution in matters such as pharmaceuticals, biomedical prosthetics, treatment methods, instrumentation, microscopy, lasers, optics and nanosignal acquisition.
Prior to joining the firm, Fairman was a research scientist in the areas of molecular biology, ion channel characterization and metabolic and cardiovascular physiology. Before pursuing graduate studies, he worked in the industry as an analytical chemist with a particular emphasis on EPA superfund toxic site analysis.
Fairman received his law degree from the University of Wisconsin Law School and a Ph.D. in biomedical sciences (human physiology) from the University of Hawaii, John A. Burns School of Medicine. He received his bachelor’s degree in biology from James Madison University. Fairman is admitted to practice with the United States Patent and Trademark Office, the Wisconsin Supreme Court and the Western District of Wisconsin.
Founded in 1957, Godfrey & Kahn maintains offices in Milwaukee, Madison (LaFollette Godfrey & Kahn), Appleton, Green Bay, and Waukesha. With more than 180 attorneys, Godfrey & Kahn provides legal and business advice to clients ranging from small businesses and governmental entities to large privately and publicly held national and international companies. For more information, visit our web site at www.gklaw.com.
